BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), ...
Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback